SVB Wealth’s Ginkgo Bioworks DNA Stock Holding History

SVB Wealth’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,374	Closed	-$99K	–	811
2025 Q1	$99K	Hold	17,374	–	–	﹤0.01%	407
2024 Q4	$171K	Buy	+17,374	New	+$149K	﹤0.01%	692
2024 Q3	–	Sell	-17,375	Closed	-$232K	–	172
2024 Q2	$232K	Sell	17,375 -22	-0.1%	-$656	0.01%	635
2024 Q1	$807K	Sell	17,397 -25	-0.1%	-$1.29K	0.02%	386
2023 Q4	$1.18M	Sell	17,422 -77	-0.4%	-$4.71K	0.03%	313
2023 Q3	$1.27M	Sell	17,499 -59	-0.3%	-$4.72K	0.03%	284
2023 Q2	$1.31M	Buy	17,558 +105	+0.6%	+$6.21K	0.02%	300
2023 Q1	$928K	Sell	17,453 -4	-0%	-$253	0.01%	391
2022 Q4	$1.18M	Sell	17,457 -27	-0.2%	-$2.48K	0.02%	365
2022 Q3	$2.18M	Sell	17,484 -1,243	-7%	-$148K	0.03%	247
2022 Q2	$1.78M	Buy	+18,727	New	+$2.28M	0.03%	233

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SVB Wealth's DNA Position: Q2 2025 in Review

SVB Wealth sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 17,374 shares — an estimated $99K sold.

SVB Wealth first reported a position in DNA in Q2 2022 and held it in 11 quarters. The position peaked at $2.18M in Q3 2022. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

SVB Wealth reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 17,374 Ginkgo Bioworks shares in Q2 2025, an estimated $99K.
SVB Wealth first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 11 quarters.
SVB Wealth's Ginkgo Bioworks position peaked at $2.18M in Q3 2022.
166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.